课题基金 / 基金详情

Bioengineered chimpanzee adenovirus-based vaccines against tuberculosis: Optimization of immunologic property, formulation and delivery for bench-to-human applications

Bioengineered chimpanzee adenovirus-based vaccines against tuberculosis: Optimization of immunologic property, formulation and delivery for bench-to-human applications
基于黑猩猩腺病毒的生物工程结核病疫苗:优化免疫特性、配方和交付以用于人体应用
批准号:
446321-2013
负责人:
Xing, Zhou
金额:
$22.9万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-01-01 至 2015-12-31

项目摘要

项目成果

Xing, Zhou的其他基金

相似基金

相关文献

中文摘要
翻译
肺结核(TB)是全球主要的传染性死亡原因之一。结核病仍然是一个严重的健康问题,
英文摘要
Lung tuberculosis (TB) is one of the leading global infectious causes of death. TB still remains a serious health concern in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioengineered chimpanzee adenovirus-based vaccines against tuberculosis: Optimization of immunologic property, formulation and delivery for bench-to-human applications
  • 批准号:
    446321-2013
  • 项目类别:
    Collaborative Health Research Projects
  • 资助金额:
    $12.56万
  • 财政年份:
    2013
  • 负责人:
    Xing, Zhou
  • 依托单位:
Regulation of NK cell biology by lung macrophage-derived interleukin-15
  • 批准号:
    418232-2012
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.48万
  • 财政年份:
    2012
  • 负责人:
    Xing, Zhou
  • 依托单位:
海外基金